http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2302402-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2874a198cb5a3593494d36246691632 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
| filingDate | 1998-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_386ace96fd49ab743a4283e89608f8e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cd707b3e838b6375c331a497f153961 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77b02e658d90b33154be61a25019c23a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7223d243fa46d5289382df82d20602a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e014403ec29842e537771437a025e64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b06eca0d4529b9e94804ddb41b7438cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9886d49789db210188e6e3fb12471da7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d66f3c73ed73b77074f6d656dffc667 |
| publicationDate | 2008-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2302402-C |
| titleOfInvention | Stereoisomeric indole compounds, process for the preparation of the same, and use thereof |
| abstract | Novel stereoisomeric indole compounds of the formula (1), a process for the preparation the same, and use thereof (SEE FORMULA 1) wherein, Y represents the group (SEE FORMULA 2) (SEE FORMULA 3) wherein, X represents alkyl group having 1-5 carbon atom(s) (the alkyl group may be substituted with hydroxyl group, carboxyl group, amino group, methylthio group, mercapto group, guanidyl group, imidazolyl group or benzyl group), and R1 and R2 represent each independently hydrogen atom, alkyl group, aralkyl group, cycloalkyl group or aryl group; R represents hydrogen atom, alkyl group, aralkyl group, cycloalkyl group, aryl group, monovalent metal, amine or ammonium; and the symbol represents a position of an asymmetric carbon atom. The above-mentioned compounds can be prepared by condensing tryptophan with a stereoisomeric .alpha.-amino acid or carboxylic acid to form an amide form and subjecting or carboxylic acid to form an amide form and subjecting the amide form to oxidative cyclization to form an oxazole ring at once. The compounds exhibit physiological activities such as inhibitory action against lipid peroxidation, and can be therefore utilized in the form of lipid peroxidation inhibitors containing the same as the active ingredient. |
| priorityDate | 1997-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.